Skip to main content
NCBI home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1991 Apr;44(4):285–289. doi: 10.1136/jcp.44.4.285

Expression of MHC class II antigens by conjunctival epithelial cells in trachoma: implications concerning the pathogenesis of blinding disease.

D C Mabey 1, R L Bailey 1, D Dunn 1, D Jones 1, J H Williams 1, H C Whittle 1, M E Ward 1
PMCID: PMC496899  PMID: 2030145

Abstract

In an attempt to understand the pathogenesis of corneal changes and conjunctival scarring in trachoma, which are responsible for blindness in some 7 million people worldwide, the surface expression of major histocompatibility complex class II antigens on conjunctival epithelial cells was sought in patients with different clinical features of the disease. Class II expression was significantly associated with active (inflammatory) trachoma, but an independent association with corneal pannus or conjunctival scarring could not be shown. Longitudinal data suggest that class II expression may antedate clinically active disease and persist after it has resolved.

Full text

PDF
285

Images in this article

287Image
on p.287

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baccarini M., Bistoni F., Puccetti P., Garaci E. Natural cell-mediated cytotoxicity against Candida albicans induced by cyclophosphamide: nature of the in vitro cytotoxic effector. Infect Immun. 1983 Oct;42(1):1–9. doi: 10.1128/iai.42.1.1-9.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bailey R., Osmond C., Mabey D. C., Whittle H. C., Ward M. E. Analysis of the household distribution of trachoma in a Gambian village using a Monte Carlo simulation procedure. Int J Epidemiol. 1989 Dec;18(4):944–951. doi: 10.1093/ije/18.4.944. [DOI] [PubMed] [Google Scholar]
  3. Byrne G. I., Grubbs B., Dickey T. J., Schachter J., Williams D. M. Interferon in recovery from pneumonia due to Chlamydia trachomatis in the mouse. J Infect Dis. 1987 Dec;156(6):993–996. doi: 10.1093/infdis/156.6.993. [DOI] [PubMed] [Google Scholar]
  4. Byrne G. I., Grubbs B., Marshall T. J., Schachter J., Williams D. M. Gamma interferon-mediated cytotoxicity related to murine Chlamydia trachomatis infection. Infect Immun. 1988 Aug;56(8):2023–2027. doi: 10.1128/iai.56.8.2023-2027.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cordell J. L., Falini B., Erber W. N., Ghosh A. K., Abdulaziz Z., MacDonald S., Pulford K. A., Stein H., Mason D. Y. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem. 1984 Feb;32(2):219–229. doi: 10.1177/32.2.6198355. [DOI] [PubMed] [Google Scholar]
  6. Daar A. S., Fuggle S. V., Fabre J. W., Ting A., Morris P. J. The detailed distribution of MHC Class II antigens in normal human organs. Transplantation. 1984 Sep;38(3):293–298. doi: 10.1097/00007890-198409000-00019. [DOI] [PubMed] [Google Scholar]
  7. Detels R., Alexander E. R., Dhir S. P. Trachoma in Punjabi Indians in British Columbia: a prevalence study with comparisons to India. Am J Epidemiol. 1966 Jul;84(1):81–91. doi: 10.1093/oxfordjournals.aje.a120630. [DOI] [PubMed] [Google Scholar]
  8. Duc-Goiran P., Zernicki L. Interferons induced by Chlamydia trachomatis in human lymphocyte cultures. Biomedicine. 1981 Sep;34(2):88–93. [PubMed] [Google Scholar]
  9. Fellous M., Nir U., Wallach D., Merlin G., Rubinstein M., Revel M. Interferon-dependent induction of mRNA for the major histocompatibility antigens in human fibroblasts and lymphoblastoid cells. Proc Natl Acad Sci U S A. 1982 May;79(10):3082–3086. doi: 10.1073/pnas.79.10.3082. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Foulis A. K. Class II major histocompatibility complex and organ specific autoimmunity in man. J Pathol. 1986 Sep;150(1):5–11. doi: 10.1002/path.1711500103. [DOI] [PubMed] [Google Scholar]
  11. Kaplan G., Nusrat A., Sarno E. N., Job C. K., McElrath J., Porto J. A., Nathan C. F., Cohn Z. A. Cellular responses to the intradermal injection of recombinant human gamma-interferon in lepromatous leprosy patients. Am J Pathol. 1987 Aug;128(2):345–353. [PMC free article] [PubMed] [Google Scholar]
  12. Mabey D. C., Robertson J. N., Ward M. E. Detection of Chlamydia trachomatis by enzyme immunoassay in patients with trachoma. Lancet. 1987 Dec 26;2(8574):1491–1492. doi: 10.1016/s0140-6736(87)92623-7. [DOI] [PubMed] [Google Scholar]
  13. Morrison R. P., Belland R. J., Lyng K., Caldwell H. D. Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein. J Exp Med. 1989 Oct 1;170(4):1271–1283. doi: 10.1084/jem.170.4.1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Nichols R. L., Bell S. D., Jr, Murray E. S., Haddad N. A., Bobb A. A. Studies on trachoma. V. Clinical observations in a field trial of bivalent trachoma vaccine at three dosage levels in Saudi Arabia. Am J Trop Med Hyg. 1966 Jul;15(4):639–647. [PubMed] [Google Scholar]
  15. Ottenhoff T. H., Ab B. K., Van Embden J. D., Thole J. E., Kiessling R. The recombinant 65-kD heat shock protein of Mycobacterium bovis Bacillus Calmette-Guerin/M. tuberculosis is a target molecule for CD4+ cytotoxic T lymphocytes that lyse human monocytes. J Exp Med. 1988 Nov 1;168(5):1947–1952. doi: 10.1084/jem.168.5.1947. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Schachter J., Moncada J., Dawson C. R., Sheppard J., Courtright P., Said M. E., Zaki S., Hafez S. F., Lorincz A. Nonculture methods for diagnosing chlamydial infection in patients with trachoma: a clue to the pathogenesis of the disease? J Infect Dis. 1988 Dec;158(6):1347–1352. doi: 10.1093/infdis/158.6.1347. [DOI] [PubMed] [Google Scholar]
  17. Wang S. P., Grayston J. T., Alexander E. R. Trachoma vaccine studies in monkeys. Am J Ophthalmol. 1967 May;63(5 Suppl):1615–1630. doi: 10.1016/0002-9394(67)94155-4. [DOI] [PubMed] [Google Scholar]
  18. Wang S. P., Grayston J. T. Pannus with experimental trachoma and inclusion conjunctivitis agent infection of Taiwan monkeys. Am J Ophthalmol. 1967 May;63(5 Suppl):1133–1145. doi: 10.1016/0002-9394(67)94095-0. [DOI] [PubMed] [Google Scholar]
  19. Ward M., Bailey R., Lesley A., Kajbaf M., Robertson J., Mabey D. Persisting inapparent chlamydial infection in a trachoma endemic community in The Gambia. Scand J Infect Dis Suppl. 1990;69:137–148. [PubMed] [Google Scholar]
  20. Woolridge R. L., Grayston J. T., Chang I. H., Cheng K. H., Yang C. Y., Neave C. Field trial of a monovalent and of a bivalent mineral oil adjuvant trachoma vaccine in Taiwan school children. Am J Ophthalmol. 1967 May;63(5 Suppl):1645–1650. doi: 10.1016/0002-9394(67)94158-x. [DOI] [PubMed] [Google Scholar]
  21. Young E., Stark W. J. In vitro immunological function of human corneal fibroblasts. Invest Ophthalmol Vis Sci. 1988 Sep;29(9):1402–1406. [PubMed] [Google Scholar]
  22. Zhong G. M., de la Maza L. M. Activation of mouse peritoneal macrophages in vitro or in vivo by recombinant murine gamma interferon inhibits the growth of Chlamydia trachomatis serovar L1. Infect Immun. 1988 Dec;56(12):3322–3325. doi: 10.1128/iai.56.12.3322-3325.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES